EUVIMEDEUVIMED entdecken
Crossref

Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?

Hatice Yılmaz Dağlı iD, Reha Artan iD, Dudu Duygu Civan iD, Nurel İnan Aydemir iD, Aygen Yılmaz iD

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Hatice Yılmaz Dağlı und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Gastroenterology, Akdeniz University, Antalya, Turkey. Hauptthemen laut MEDLINE: Liver Transplantation, Hyperlipoproteinemia Type II, Cholesterol, LDL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To examine the long‐term results and treatment effectiveness of liver transplantation (LT) in the treatment of homozygous familial hypercholesterolemia (HoFH) in children and adolescents.

Method

Patients who underwent LT due to HoFH between 2007 and 2023 were included in the study. The patients' demographic data, clinical findings, preoperative and postoperative laboratory examinations, transplantation complications, and postoperative disease courses were evaluated.

Results

There were five boys with an average age of 6.2 (median: 6, range 4–10) years in the study. The average total cholesterol level of the patients before transplantation was 923 (median: 950, range: 780–1002) mg/dL and the average LDL‐cholesterol level was 864 (median: 852, range: 770–957) mg/dL. No patients died of transplant‐related complications. After an average follow‐up of 9.2 (median: 9, range: 1.5–16) years, the average total cholesterol level of the patients was 197 (median: 164, range: 137–359) mg/dL, and the average LDL‐cholesterol level was 138 (median: 92, range: 85–313) mg/dL. Four (80%) patients developed atherosclerotic cardiovascular disease during follow‐up, and two (40%) died of this cause.

Conclusion

LT in the treatment of HoFH did not help our patients reach the target LDL‐cholesterol level after transplantation and did not prevent the development of cardiovascular disease. Therefore, LT alone is not curative in the treatment of HoFH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHyperlipoproteinemia Type IICholesterol, LDLHumansMaleChildChild, PreschoolTreatment OutcomeFemaleFollow-Up StudiesHomozygoteAdolescentRetrospective StudiesCholesterol

Stichwörter der Autor:innen

childfamilial hypercholesterolemialiver transplantation

Substanzen

Cholesterol, LDLCholesterol

Autor:innen und Institutionen

  • Department of Pediatric Gastroenterology, Akdeniz University, Antalya, Turkey.

ORCID-Profile: Hatice Yılmaz Dağlı, Reha Artan, Dudu Duygu Civan, Nurel İnan Aydemir, Aygen Yılmaz

Zitieren

APA

Yılmaz Dağlı, H., Artan, R., Civan, D. D., İnan Aydemir, N., & Yılmaz, A. (2024). Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?. Pediatric Transplantation. https://doi.org/10.1111/petr.14853

Vancouver

Yılmaz Dağlı H, Artan R, Civan DD, İnan Aydemir N, Yılmaz A. Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?. Pediatric Transplantation. 2024. doi:10.1111/petr.14853

BibTeX
@article{YlmazDal2024,
  author = {Yılmaz Dağlı, Hatice and Artan, Reha and Civan, Dudu Duygu and İnan Aydemir, Nurel and Yılmaz, Aygen},
  title = {Is Liver Transplantation Alone an Effective Treatment for Homozygotic Familial Hypercholesterolemia in Children?},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14853}
}
Kostenlos starten →